VR Adviser, LLC Q3 2023 Filing

Filed November 14, 2023

Portfolio Value

$949.9T

Holdings

37

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (37 positions)

#StockSharesValue% PortfolioType
1
APGEAPOGEE THERAPEUTICS INC
8,493,321$180.9M0.00%
2
RAYZEBIO INC
4,016,847$89.2M0.00%
3
VRDNVIRIDIAN THERAPEUTICS INC
3,082,622$47.3M0.00%
4
COGTCOGENT BIOSCIENCES INC
4,684,167$45.7M0.00%
5
TSHATAYSHA GENE THERAPIES INC
14,444,444$45.6M0.00%
6
MRUSMERUS N V
1,726,214$40.7M0.00%
7
ELVNENLIVEN THERAPEUTICS INC
2,954,902$40.4M0.00%
8
FDMT4D MOLECULAR THERAPEUTICS IN
3,000,000$38.2M0.00%
9
PHVSPHARVARIS N V
1,563,513$32.6M0.00%
10
CABACABALETTA BIO INC
1,973,253$30.0M0.00%
11
KALVKALVISTA PHARMACEUTICALS INC
2,916,667$28.1M0.00%
12
GHRSGH RESEARCH PLC
2,744,125$27.6M0.00%
13
HLVXHILLEVAX INC
2,037,313$27.4M0.00%
14
YB4PSAVARA INC
7,184,865$27.2M0.00%
15
RYTMRHYTHM PHARMACEUTICALS INC
1,090,000$25.0M0.00%
16
AMBRX BIOPHARMA INC
2,070,000$23.8M0.00%
17
TVTXTRAVERE THERAPEUTICS INC
2,623,677$23.5M0.00%
18
DYNDYNE THERAPEUTICS INC
2,173,913$19.5M0.00%
19
CELCCELCUITY INC
2,105,386$19.2M0.00%
20
TERNTERNS PHARMACEUTICALS INC
3,092,273$15.6M0.00%
21
MERSANA THERAPEUTICS INC
11,328,000$14.4M0.00%
22
APLTAPPLIED THERAPEUTICS INC
5,658,034$14.1M0.00%
23
ORICORIC PHARMACEUTICALS INC
2,142,856$13.0M0.00%
24
DNTHDIANTHUS THERAPEUTICS INC
927,706$12.7M0.00%
25
ADVMCHFADVERUM BIOTECHNOLOGIES INC
6,573,300$9.9M0.00%
26
PRAXPRAXIS PRECISION MEDICINES I
5,304,410$9.1M0.00%
27
SLRNACELYRIN INC
864,332$8.8M0.00%
28
TRVITREVI THERAPEUTICS INC
3,422,397$7.5M0.00%
29
ACRSACLARIS THERAPEUTICS INC
1,040,754$7.1M0.00%
30
MISTMILESTONE PHARMACEUTICALS IN
2,208,812$6.8M0.00%
31
PLRXPLIANT THERAPEUTICS INC
288,949$5.0M0.00%
32
SGMTSAGIMET BIOSCIENCES INC
515,000$4.5M0.00%
33
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
295,034$3.6M0.00%
34
LYRALYRA THERAPEUTICS INC
924,170$3.6M0.00%
35
OLMAOLEMA PHARMACEUTICALS INC
77,042$951K0.00%
36
RLYBRALLYBIO CORP
268,532$904K0.00%
37
AFFIMED N V
1,428,571$682K0.00%